دورية أكاديمية
Corrigendum to “P-137: ITHACA, A Randomized Multicenter Phase 3 Study of Isatuximab in Combination With Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma: Safety Run-in Preliminary Results” [Clinical Lymphoma Myeloma and Leukemia 21 S2 (2021) S109- S110]
| العنوان: | Corrigendum to “P-137: ITHACA, A Randomized Multicenter Phase 3 Study of Isatuximab in Combination With Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma: Safety Run-in Preliminary Results” [Clinical Lymphoma Myeloma and Leukemia 21 S2 (2021) S109- S110] |
|---|---|
| المؤلفون: | Ghobrial, Irene M., Rodríguez-Otero, Paula, Koh, Youngil, Martínez-López, Joaquín, Parmar, Gurdeep, Prince, Miles, Quach, Hang, de la Rubia, Javier, Hermansen, Emil, Hungria, Vania, Kalayoglu Besisik, Sevgi, Kim, Jin Seok, Leleu, Xavier, Peceliunas, Valdas, Schjesvold, Fredrik, Dubin, Franck, Devisme, Christine, Lepine, Lucie, Macé, Sandrine, Oprea, Corina, Mateos, María-Victoria |
| المصدر: | Clinical Lymphoma Myeloma and Leukemia ; ISSN 2152-2650 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2022 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Cancer Research, Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.clml.2022.03.011 |
| الإتاحة: | https://doi.org/10.1016/j.clml.2022.03.011Test https://api.elsevier.com/content/article/PII:S2152265022000994?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S2152265022000994?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.78DF5AF |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.clml.2022.03.011 |
|---|